Loading stock data…
WW International (WW)
$16.40+0.41 (+2.56%)
Market ClosedLast close Jun 29
WW International, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
WW International, Inc. in the Healthcare sector is trading at $16.40 with a market capitalization of $192M. Wall Street consensus targets $28.33 (3 analysts), implying a +72.8% move over the next 12 months. The stock is currently 65% below its 52-week high of $46.95, remaining 25.0% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +72.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $168.26M↑ | $162.81M↓ | $184.26M↑ | $177.00M↓ | $186.57M |
| Gross Profit | $118.67M↑ | $114.09M↓ | $133.02M↑ | $130.51M↓ | $132.88M |
| Operating Income | -$29.91M↓ | -$12.94M↓ | $10.62M↓ | $41.40M↑ | $7.35M |
| Net Income | -$52.00M↓ | -$5.83M↑ | -$56.26M↓ | $1.19B↑ | -$72.58M |
Peer Comparison
JNJUNHPFE
Fundamentals
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$191.68M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
405.39%
Volume
Today's trading volume
129,203
Recent News
3 of Wall Street’s Favorite Stocks with Warning Signs
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Consumer Discretionary - Specialized Consumer Services Stocks Q1 Teardown: WeightWatchers (NASDAQ:WW) Vs The Rest
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at WeightWatchers (NASDAQ:WW) and the best and worst performers in the consumer discretionary - specialized consumer services industry.
1 Profitable Stock to Keep an Eye On and 2 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Crocs, Sonos, and WeightWatchers Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after consumer discretionary stocks pulled back, led by a plunge in Lululemon as the company cut its full-year revenue guidance to $11.0–$11.15 billion from $11.35–$11.5 billion, citing weaker US consumer traffic, brand backlash on social media, and underperforming product launches.
How Investors Are Reacting To Eli Lilly (LLY) Expanded GLP-1 Access And Digital Obesity Ecosystem
In late May and early June 2026, Eli Lilly reported strong Phase 3 results for obesity, diabetes and oncology drugs, broadened coverage of its full obesity portfolio by all three major U.S. pharmacy benefit managers, and added Sesame and WW International’s Weight Watchers Med+ programs to its LillyDirect digital platform to improve access and support for patients. Together, these developments deepen Lilly’s presence across the entire cardiometabolic care journey, from gene-editing and...